Spoken Alpha
MESA LABORATORIES INC /CO/
Mesa Laboratories manufactures and sells life sciences tools and quality control solutions for pharmaceutical, healthcare, and medical device industries, including sterilization indicators, genetic analysis instruments, protein analysis systems, and calibration equipment.
MESA LABORATORIES INC /CO/ is a Technology company operating in Scientific & Technical Instruments with a $709.2M market cap.
Most recent reported earnings: Q2 FY2027 (Nov 4, 2026).
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-08-30.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for MLAB.
$ curl https://api.spokenalpha.com/v1/companies/MLABFAQ
Spoken Alpha indexes MLAB's earnings call transcripts at https://spokenalpha.com/companies/MLAB. Each call links to attributed speakers and parsed analyst Q&A. MESA LABORATORIES INC /CO/'s own investor relations page is at https://investors.mesalabs.com/home/.
MESA LABORATORIES INC /CO/ (MLAB) held its most recent earnings call on 2026-08-10, covering fiscal Q1 2026.
MESA LABORATORIES INC /CO/ (MLAB) operates in the Technology sector (Scientific & Technical Instruments industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2027 | 2026-11-04 | — | $2.24 | — | — | — | — | EODHD |
| Q1 FY2027 | 2026-08-09 | — | $2.55 | — | — | — | — | EODHD |
| Q4 FY2026 | 2026-05-26 | $1.83 | $1.39 | +31.5% | $63.7M | — | — | EODHD |
| Q3 FY2026 | 2026-02-02 | $1.76 | $1.47 | +19.7% | $65.1M | — | — | EODHD |
| Q2 FY2026 | 2025-11-05 | $2.11 | $1.56 | +35.3% | $60.7M | — | — | EODHD |
| Q1 FY2026 | 2026-08-09 | $2.21 | $2.55 | -13.3% | $60.1M | — | — | EODHD |
| Q4 FY2025 | 2025-05-27 | $2.25 | $1.91 | +17.8% | $62.1M | — | — | EODHD |
| Q3 FY2025 | 2025-02-03 | $0.79 | $1.51 | -47.7% | $62.8M | — | — | EODHD |
| Q2 FY2025 | 2024-11-06 | $2.16 | $1.38 | +56.5% | $57.8M | — | — | EODHD |
| Q1 FY2025 | 2024-08-04 | $1.96 | $1.55 | +26.5% | $58.2M | — | — | EODHD |
| Q4 FY2024 | 2024-05-30 | $3.70 | $-0.11 | +100.0% | $58.9M | — | — | EODHD |
| Q3 FY2024 | 2024-02-04 | $2.62 | $1.70 | +54.1% | $53.5M | — | — | EODHD |
| Q2 FY2024 | 2023-11-05 | $1.91 | $1.79 | +6.7% | $53.2M | — | — | EODHD |
| Q1 FY2024 | 2023-08-02 | $1.01 | $1.36 | -25.7% | $50.6M | — | — | EODHD |
| Q4 FY2023 | 2023-05-24 | $0.11 | $0.37 | -70.3% | $55.6M | — | — | EODHD |
| Q3 FY2023 | 2023-02-05 | $1.85 | $1.58 | +17.1% | $54.3M | — | — | EODHD |
| Q2 FY2023 | 2022-11-02 | $2.88 | $1.16 | +100.0% | $58.7M | — | — | EODHD |
| Q1 FY2023 | 2022-08-03 | $0.29 | $1.47 | -80.3% | $50.5M | — | — | EODHD |
| Q4 FY2022 | 2022-05-30 | $-0.34 | $0.48 | -100.0% | $58.9M | — | — | EODHD |
| Q3 FY2022 | 2022-02-02 | $2.35 | $1.32 | +78.0% | $54.7M | — | — | EODHD |
Source: EODHD. MLAB reported actuals as published; sparse fields render as —.